SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-024116
Filing Date
2021-05-05
Accepted
2021-05-05 16:30:05
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q rgnx-10q_20210331.htm   iXBRL 10-Q 2235130
2 EX-31.1 rgnx-ex311_82.htm EX-31.1 16935
3 EX-31.2 rgnx-ex312_81.htm EX-31.2 16906
4 EX-32.1 rgnx-ex321_80.htm EX-32.1 11292
  Complete submission text file 0001564590-21-024116.txt   9348147

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA rgnx-20210331.xsd EX-101.SCH 57912
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgnx-20210331_cal.xml EX-101.CAL 62470
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgnx-20210331_def.xml EX-101.DEF 188264
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgnx-20210331_lab.xml EX-101.LAB 447996
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgnx-20210331_pre.xml EX-101.PRE 336209
10 EXTRACTED XBRL INSTANCE DOCUMENT rgnx-10q_20210331_htm.xml XML 2152658
Mailing Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850
Business Address 9600 BLACKWELL ROAD SUITE 210 ROCKVILLE MD 20850 240-552-8181
REGENXBIO Inc. (Filer) CIK: 0001590877 (see all company filings)

IRS No.: 471851754 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37553 | Film No.: 21893839
SIC: 2836 Biological Products, (No Diagnostic Substances)